With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access

AI Summary

Merck is facilitating access to a new HIV prevention pill by enabling companies in Africa and India to produce generic versions costing as little as $5 per year per person. However, access to this drug in much of Latin America remains uncertain.

Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain.